FARS2 and prostate carcinoma: An enrichment-based pathway mapping of the androgen-regulated proteomic data sets revealed a significant disregulation of aminoacyl-tRNA synthetases and, α-subunit of PheRS in particular, indicating an increase in protein biosynthesis—a characteristic at some stage of prostate cancer progression [37].